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may be informative. Virulence determinants of M. tuberculosis include proteins transported by the Type Seven Secretion System (T7SS). M. tuberculosis contains five T7SS, also called ESAT6 secretion system (ESX), and two members, ESX-1 and ESX-5, have been shown to be involved in virulence. ESX-1 is needed for phagosomal rupture and Mycobacterium bovis bacille Calmette-Guérin (BCG) does not gain access to the cytosol because it has lost a chromosomal fragment, the RD1 region that encodes for several genes of the ESX-1 system. [10] Nevertheless, other pathogenic M. tuberculosis complex members have also the RD1 deletion, including Mycobacterium microti, Mycobacterium mungi, Mycobacterium suricatti, and the dassie bacillus. [11] And other NTM, such as Mycobacterium marinum, Mycobacterium fortuitum, or Mycobacterium komanii, express ESX-1. [12, 13] In a recent report, 41 NTM species have been characterized by whole genome sequencing. [14] They compared the genes of the Mce family that codify for secreted or cell envelope proteins, and that confers mycobacteria the ability to enter into mammalian cells. [15] [14] In addition, mycobacteria have two SecA proteins, SecA1 and accessory SecA2 and SecA2 is essential for the full virulence of M. tuberculosis, [15] but the Sec system is conserved in all the species. [14] Consequently, it seems that NTM share many of the M. tuberculosis virulence genes, but bioinformatics analysis has revealed that the phylogenetical distinction between pathogenic and nonpathogenic mycobacteria [16] may be more relevant than between the M. tuberculosis complex and NTM.
the host
As in any other infectious disease, the genetic variation of the host, originated by mutation, plays a fundamental role in the susceptibility to NTM. A majority of new mutations (mainly single nucleotide polymorphisms [SNPs]) are thought to have no effect and are deemed selectively neutral, but a few extreme deleterious mutations are lethal. Between both ends lay those variants that provide the genetic substrate for evolutionary change in response to infection. [17] The nontuberculous mycobacteriosis in highly susceptible people is classified as Mendelian susceptibility to mycobacterial disease (MSMD) [18] and is characterized by isolated infections with mycobacteria or Salmonella (also intracellular bacteria) due to a defect in the type-1 cytokine response. MSMD are frequently pediatric disorders and involve mutations in genes including IL12B, IL12RB1, IFNGR1, IFNGR2, STAT1, IKBKG, CYBB, TYK2, IRF8, and ISG15 that cause either insufficient production of interferon γ or response to the cytokine. Strikingly, the incidence of tuberculosis in MSMD patients is relatively low, likely because early death precludes the diagnosis of these immunological defects. [19] Search of SNPs that cause susceptibility to M. tuberculosis has yielded few results, despite being the most studied infectious disease. In a recent systematic review, only SNPs in IL4, TLR2, and CCL2 were reproducibly found as influential on the susceptibility to the disease [20] although many other SNPs have been identified in genome-wide association studies (GWAS). [21] In post-GWAS analysis, six intronic SNPs were found associated to tuberculosis susceptibility, located in MARCO, IFNGR2, ASHAS2, ACACA, NISCH, and TLR2. [22] Regarding susceptibility to NTM, no GWAS have been conducted so far, and these studies may be very difficult to perform for these bacteria. An important problem with this approaches such as GWAS or linkage studies is that most infectious disease susceptibility genes have too small effect sizes and/or too low a frequency to allow being detected in even hundreds of families. [23] InteractIon of the host and Pathogen wIth the envIronment Exposure to the NTM does not imply that the infected individual will develop an active disease. Dirac et al. have The interaction between environments that favor nontuberculous mycobacteria, including behavioral changes such as the widespread use of showers, and immunocompromised hosts, induced by factors such as the current use of immunosuppressive therapies, has resulted in a remarkable rise in mycobacteriosis incidence. (c) Frequent exposure of mycobacteria to immunocompromised hosts may facilitate the development of mycobacteriosis. (1) Immunocompromised hosts offer a new favorable environment that allows mycobacterial mutators to adapt and increase its virulence (darker bacilli). In contrast, immunocompetent hosts exposed to expelled mycobacteria are able to resist the infection and the transmission chain is curtailed. (2) After several cycles of exposure to immunocompromised hosts, the mycobacteria pathogenicity may increase to such degree that they become true pathogens. In this circumstance, resistant individuals to environmental mycobacteria may be unable to prevent the survival and multiplication of the new pathogen, which becomes transmissible. Under this situation, nontuberculous mycobacteriosis incidence may overcome that of Mycobacterium tuberculosis c b a postulated two models of disease acquisition. The "susceptible person" model suggests that individuals will become sick regardless of the level of exposure to the mycobacteria, whereas the "unusual dose" model states that when individuals receive an unusually high dose of bacteria will develop the disease regardless of their immune status, [24] but they do not exclude each other. Susceptible individuals are exposed to larger doses of mycobacteria because they can grow on low levels of nutrients and have the ability to form biofilms which promotes their survival and dissemination on engineered habitats such as drinking water distribution systems, hospital water systems, and household plumbing that, nowadays, represent the most important sources of NTM. [25] Tuberculosis incidence is declining, [26] and in some places, higher rates for nontuberculous mycobacterial disease have been reported. [27, 28] NTM such as Mycobacterium vaccae has been used as immunotherapy for tuberculosis, [29] and a similar immunological cross-reaction may protect M. tuberculosis infected individuals from NTM. Consequently, less exposure to M. tuberculosis may cause increased NTM infections. Furthermore, M. bovis BCG has also been suggested to offer some immunity and countries that have halted vaccination campaigns have suffered higher incidence rates of nontuberculous mycobacterial diseases. [30, 31] changes In factors that affect the ePIdemIology of nontuberculous mycobacterIa
Progress in microbiological methodology
Researchers have been puzzled on an increased number of reports of NTM infections in the last decades. An early explanation was that technical improvements in the isolation and identification of mycobacteria prompted a wider recognition of NTM as relevant pathogens. The use of fluorescence microscopy, culture in broth-based systems, and the development of rapid methods for identification, including polymerase chain reaction-restriction enzyme assay or high-performance liquid chromatography, [32] have allowed a better recovery and characterization of mycobacteria in clinical laboratories. Some authors believe that these improvements are behind the recognized increase in nontuberculous mycobacterial disease, [33] but others think that they are not the only reason. [34, 35] In an interesting example, NTM isolation in Ontario in 2007, [36] Anthonisen assessed the possible reasons for the increased isolation. He remarked that there were no changes in isolation techniques at that time. He also ruled out general awareness by physicians because an increase in the number of cultures requested would have also implied a higher number of negative cultures that were not detected. [35] Some authors have reached the conclusion that technical progress contributes but does not justify the observed changes in incidence. [28, 37] Changes in the host A microorganism may emerge as a pathogen because of changes in host susceptibility to infection. Important factors that will influence are the numeric increase in immunocompromised patients, aging of the population, and malnutrition [38] [ Figure 1b ]. Unlike diseases such as cancer that frequently arises from somatic mutations, hereditary diseases such as MSDS are supposed to be constant in the population. [38] Acquired immunodeficiencies also contribute to the number of patients with NTM. The most compelling example is the human immunodeficiency virus, commonly linked to mycobacteriosis. Nevertheless, the application of highly active antiretroviral therapy has reduced the rates of these infections. [39] Other acquired immunodeficiencies are those induced by anti-cytokine autoantibodies, especially against interferon γ and granulocyte macrophage colony-stimulating factor, more frequently associated to nontuberculous mycobacterial disease than to tuberculosis, [40] but their current epidemiological importance is unknown. In addition, immunosuppression induced by medical treatments for oncologic, rheumatologic, and neurologic disorders is increasing [38] and is a major cause of concern for nontuberculous mycobacteriosis. The use of tumor necrosis factor-α inhibitors such as etanercept, infliximab, or adalimumab increases the risk of tuberculosis 4-10 fold, but also of nontuberculous mycobacterial disease. [41] Furthermore, the incidence of autoimmune diseases is increasing in developed countries, [42] and several other immunosuppressive agents used for their treatment such as corticosteroids, leflunomide or hydroxychloroquine also increase the risk. [43] Aging is another factor that affects the susceptibility, probably linked to the immunosenescence phenomenon. Prevalence is highest in people aged over 65. Given that elderly population is increasing, it is projected that epidemiology of NTM will remarkably change in the next few years. NTM infections in some elderly present particular features, such as those in the Lady Windermere syndrome, which is characteristic of older age females with no history of smoking. [44] A last important factor in host susceptibility is malnutrition. The biological basis of poor nutritional status as a risk factor for tuberculosis has been well defined. [45] Malnutrition [46] and eating disorders [47] has been associated to nontuberculous mycobacterial disease. Although tuberculosis in the obese population is lower than in the nonobese population, [48] obesity increases the tendency to diabetes, which is known as an independent factor of active tuberculosis. [49] Although there is little information relative to the importance of diabetes for nontuberculous mycobacterial disease, it may be expected that it has a negative influence. [50] Changes in the pathogen Although M. tuberculosis strains have been isolated from the environment, [51] and compelling evidence suggest that M. leprae may survive outside their hosts, [52] mycobacteria from the M. tuberculosis complex and M. leprae are considered obligate pathogens, whereas NTM are viewed as opportunistic and their source is supposed to be exclusively the environment. [53] Human-to-human has not been considered a major route of transmission for NTM. A recent study using whole genome sequencing of Mycobacterium abscessus isolates from cystic fibrosis patients identified multiple clades of near-identical isolates from geographically diverse locations. [54] The authors suggested widespread transmission within the global cystic fibrosis community. Moreover, earlier reports also suggested the person-to-person transmission of Mycobacterium kansasii. [55] [56] [57] To consider NTM as an airborne pathogen, it should follow the steps proposed by Herfst et al.
First, association of the pathogen to aerosols or dust particles; second, deposition of the pathogen in the recipient, usually by inhalation; third, amplification of the pathogen, either in the respiratory tract or in peripheral tissues; and fourth, its emergence at the site of shedding (frequently the upper respiratory tract) in sufficient loads and capable of expulsion. [58] The frequent detection of acid-fast bacilli in sputum suggests that the first and second steps are easily accomplished by NTM. The reason for the difficulties of transmission will probably lie in the third step because an appropriate immune response will impair the amplification of the pathogen. If the immune response is no longer successful, NTM may become transmissible [ Figure 1c ]. Additional evidence that supports the transmissibility of NTM has been addressed in a Caenorhabditis elegans model, and it has been confirmed that Mycobacterium avium shed by a host through the digestive route is able to infect a new one. [59] The impression that most NTM are mostly colonizers may also be changing. Since some mycobacteria were recognized as relevant pathogens, [1] they have all been perceived as potentially pathogenic. [60] Human macrophages infected in vitro with Mycobacterium gordonae, frequently regarded as a nonpathogenic mycobacterium, or with M. tuberculosis, are unable to restrict the intracellular multiplication of the mycobacteria, suggesting that M. gordonae share with M. tuberculosis some of the means to resist destruction by macrophages. [61] Many mycobacteria have been reported in one or more clinical cases, although erroneous identification remains an important problem. [62] Mutator microorganisms, with an increased rate of spontaneous mutations resulting from defects in DNA repair or error avoidance systems, can become resistant to antibiotics, evolve to a higher level of virulence, and acquire persistence or transmissibility. [63] NTM may take advantage from positive selection of mutators to survive in the environment and to invade humans. Although the first evidence for a specific environment driving the selection of hypermutable strains was obtained in a study of Pseudomonas aeruginosa in cystic fibrosis patients, [64] mycobacteria also seem to share a mutator phenotype. [65] A remarkable example is the single natural nucleotide mutation that is able to convert a human-specific Staphylococcus aureus strain into one that can infect rabbits. [66] NTM may be already following this path to enhance virulence in immunocompromised chronically infected individuals [ Figure 1c ]. Twenty years ago, NTM isolates were considered unimportant in patients with cystic fibrosis; [67] but in the last few decades, a few clones have been able to spread widely within this population, and they share several pathogenic features that suggest the establishment of transmission chains that may have permitted M. abscessus to evolve from an environmental organism to a true human lung pathogen. [54] This adaptation to the human host is worrying because it may have taken place in a few years. Another example is M. kansasii which has been classified into seven subtypes. Strains from the subtype 1 are the most common in humans [68] suggesting that they are better adapted to the host. In addition, a study in Australia showed that very few strains of M. kansasii obtained from municipal waters were similar or related to clinical isolates, [69] possibly indicating that isolates from humans have become different from their environmental counterparts.
concludIng remarks
If the incidence and prevalence of the disease continue to increase, the problem of drug-resistant NTM will become bigger than tuberculosis, [70] and we need to take action now against the worldwide nontuberculous mycobacterial disease epidemic. [71] An appropriate measure is to make it a reportable disease to public health authorities. The benefits of reporting extrapulmonary nontuberculous mycobacterial disease are evident because most of the times, they represent true disease and could come from contaminated surgical, cosmetic, or other procedures that public health action may prevent. The reasons for reporting pulmonary NTM are more difficult to justify because frequently, they are not associated to disease. Nevertheless, reporting can improve our knowledge on the current situation of nontuberculous mycobacterial epidemic and allow us to build up a capacity for diagnosis and treatment at local and international levels. [72] Mycobacterial genotyping is an additional measure that will help the identification of environmental strains that may have already taken the path of adaptation to the human host. Genotyping systems are well developed for the M. tuberculosis complex. [73] In contrast, comparatively fewer efforts have been performed in NTM. Several objectives will be accomplished by genotyping, including the identification of virulent strains for risk analysis, strain tracking to identify source of exposure, and description of population structures and forces acting on them. [74] Nowadays, next-generation sequencing will be the methodology of election, but given the large number of NTM species and their lower virulence, it seems unlikely that its use will become widespread. Simpler and more cost-effective alternatives would be more appropriate. These diseases deserve to be taken rather seriously and further research should help us dealing with their emergent nature. It may be safely predicted that their incidence will keep escalating.
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